|
1-Piperidinamine, N-hydroxy-N-nitroso-
|
|
56329-24-9
|
|
NA
|
|
148706-15-7
|
|
Beigene-283
|
LIFIRAFENIB
|
1446090-79-4
|
|
Empagliflozin impurity K
|
恩格列凈雜質(zhì)K
|
|
|
JQKD-82
|
JQKD-82
|
2410512-38-6
|
|
ML339
|
化合物ML339
|
2579689-83-9
|
|
INE963
|
化合物INE963
|
2640567-43-5
|
|
CEE321
|
4-((2-氯苯基)氨基)-6-((6-甲基吡啶-2-基)氨基)煙酰胺
|
2098545-89-0
|
|
Empagliflozin Impurity D
|
恩格列凈雜質(zhì)D
|
|
|
4-Borono-D-phenylalanine
|
4-硼-D-苯丙氨酸 B10
|
111821-49-9
|
|
Bocidelpar
|
化合物BOCIDELPAR
|
2095128-20-2
|
|
CK-274
|
AFICAMTEN
|
2364554-48-1
|
|
MIPS-521
|
MIPS-521
|
1146188-19-3
|
|
BRD0639
|
化合物BRD0639
|
|
|
5-Thiazolecarboxamide, N-[(2S)-2-(4-chlorophenyl)-2-(4-morpholinyl)ethyl]-2-(2-pyrimidinyl)-4-(trifluoromethyl)-
|
5-THIAZOLECARBOXAMIDE, N-[(2S)-2-(4-CHLOROPHENYL)-2-(4-MORPHOLINYL)ETHYL]-2-(2-PYRIMIDINYL)-4-(TRIF
|
2097117-06-9
|
|
WAY- 639483
|
WAY-639483
|
791125-94-5
|
|
EMpagliflozin iMpurity 6
|
恩格列凈雜質(zhì)M
|
1620758-21-5
|
|
Inaxaplin
|
化合物INAXAPLIN
|
2446816-88-0
|
|
Complement factor D-IN-2
|
2-Azabicyclo[3.1.0]hexane-3-carboxamide, 2-[2-[3-acetyl-5-(2-methyl-5-pyrimidinyl)-1H-indazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-, (1R,3S,5R)-
|
1903742-34-6
|
|
AOH1996
|
AOH1996
|
2089314-64-5
|
|
ONT-093
|
ONT-093
|
216227-54-2
|
|
NCRW0005-F05
|
化合物NCRW0005-F05
|
342779-66-2
|
|
Empagliflozin Impurity 17
|
恩格列凈雜質(zhì)L
|
2452301-27-6
|
|
SOD1-Derlin-1 inhibitor 56-59
|
SOD1-Derlin-1 inhibitor 56-59
|
2170170-27-9
|
|
RIPK2 inhibitor OD36
|
6-Chloro-10,11,14,17-tetrahydro-13H-1,16-etheno-4,8-metheno-1H-pyrazolo[3,4-g][1,14,4,6]dioxadiazacyclohexadecine hydrochloride
|
1638644-62-8
|
|
Isothiazolo[5,4-b]pyridin-6-amine
|
異噻唑并[5,4-B]吡啶-6-胺
|
1352905-20-4
|
|
2-Piperidinemethanol, 1-[2-[4-[[4-(3,4-dichlorophenyl)-2-thiazolyl]amino]phenyl]ethyl]-4-hydroxy-, (2R,4S)-
|
化合物 AMGEN-23
|
1448706-15-7
|
|
Empagliflozin Impurity N
|
恩格列凈雜質(zhì)N
|
|
|
Tebanicline hydrochloride
|
ABT594鹽酸鹽
|
203564-54-9
|
|
CDK4/6-IN-6
|
CDK4/6-IN-6
|
2380321-51-5
|
|
AZD-9574
|
AZD-9574
|
2756333-39-6
|
|
WAY-600
|
6-(1H-吲哚-5-基)-4-(4-嗎啉基)-1-[1-(3-吡啶基甲基)-4-哌啶基]-1H-吡唑并[3,4-D]嘧啶
|
1062159-35-6
|
|
CD 12322
|
恩格列凈雜質(zhì)B
|
|
|
3-amino-N-(2,4-dibromophenyl)-6-(pyridin-3-yl)thieno[2,3-b]pyridine-2-carboxamide
|
化合物T60119
|
840461-03-2
|
|
Eliapixant
|
依利哌嗪
|
1948229-21-7
|
|
WAY-331996
|
WAY-331996
|
902168-07-4
|
|
Empagliflozin Impurity O
|
恩格列凈雜質(zhì)O
|
|
|
SKF 89976A hydrochloride
|
1 - (4,4 - 二苯基-3 - 丁烯基)- 3 -哌啶鹽酸鹽
|
85375-15-1
|
|
TC-G 1001
|
TC-G 1001
|
494191-73-0
|
|
SR 1664
|
4′-[[2,3-Dimethyl-5-[[[(1S)-1-(4-nitrophenyl)ethyl]amino]carbonyl]-1H-indol-1-yl]methyl]- [1,1′-Biphenyl]-2-carboxylic acid
|
1338259-05-4
|
|
AMP-945
|
AMP-945
|
1393653-34-3
|
|
Ximelagatran
|
希美加群
|
192939-46-1
|
|
3-Piperidinecarboxamide, N-(4,6-difluoro-2-benzothiazolyl)-1-[2-(dimethylamino)ethyl]-
|
化合物MCUF-651
|
2747162-85-0
|
|
N-[4-(6-Fluoro-3,4-dihydro-2(1H)-isoquinolinyl)-2,6-dimethylphenyl]-3,3-dimethylbutanamide
|
N-[4-(6-氟-3,4-二氫-2(1H)-異喹啉基)-2,6-二甲基苯基]-3,3-二甲基丁酰胺
|
1009344-33-5
|
|
RY785
|
RY785
|
1393748-80-5
|
|
(R)-(-)-3-Hydroxytetrahydrofuran
|
恩格列凈雜質(zhì)C
|
86087-24-3
|
|
KN-62
|
1-[N,O-二(5-異喹啉磺酰基)-N-甲基-L-型酪氨酸]-4-苯基哌嗪
|
127191-97-3
|
|
SCD1 inhibitor-3
|
化合物SCD1 INHIBITOR-3
|
1282606-48-7
|
|
WAY-603656
|
WAY-603656
|
717118-15-5
|
|
WAY-332006
|
WAY-332006
|
901751-85-7
|
|
EN106
|
EN 106
|
757192-67-9
|
|
GSK251
|
GSK251
|
2125968-05-8
|
|
YTX-465Chemical Structure
|
YTX-465
|
2225824-53-1
|
|
GLPG2938
|
GLPG2938
|
2130996-00-6
|
|
KL-11743
|
KL11743
|
1369452-53-8
|